a month ago
As a company, Gilead is now worth over $15 billion more than before the pandemic, in part because it expects to make enormous profits by charging over $3,000 for a drug they had already developed years ago.

Their greed must be stopped.
Comments 0
العربية 中文(简体) 中文(繁體) Čeština Nederlands English suomi Français Deutsch हिन्दी, हिंदी Indonesia Italiano 日本語 한국어 Bahasa Melayu Polski Português Русский Español Kiswahili Svenska Tagalog ภาษาไทย Türkçe Tiếng Việt